09.02.2013 Views

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BILL & MELINDA GATES FOUNDATION 56-2618866<br />

FORM <strong>990</strong><strong>PF</strong>, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR<br />

RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR<br />

AND<br />

ATTACHMENT 18 (CONT'D)<br />

RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT<br />

MDC INC NONE TO CREATE A BUSINESS PLAN FOR THE NEXT PHASE<br />

500,000.<br />

PO BOX 17268 509(A)(1)<br />

CHAPEL HILL, NC 275167268<br />

OF MDC'S ORGANIZATIONAL DEVELOPMENT AND TO<br />

DEVELOP AN IMPLEMENTATION PLAN FOR MDC'S<br />

PROPOSED POSTSECONDARY SUCCESS WORK IN THE<br />

MDRC NONE TO SUPPORT AN EVALUATION PROJECT<br />

200,000.<br />

16 EAST 34TH ST 509(A)(1)<br />

19TH FLOOR<br />

NEW YORK, NY 100164326<br />

MDRC NONE TO SUPPORT EVALUATIONS OF THREE INTERVENTIONS<br />

4,000,000.<br />

16 EAST 34TH ST 509(A)(1)<br />

19TH FLOOR<br />

NEW YORK, NY 100164326<br />

SOUTH<br />

THAT BREAK THE INTERGENERATIONAL TRANSMISSION<br />

OF POVERTY: PERFORMANCE-BASED SCHOLARSHIPS,<br />

LEARNING COMMUNITIES AND NATIONAL GUARD YOUTH<br />

CHALLENGE<br />

MED BIOTECH LABORATORIES NONE MARGARET NJOROGE AND THOMAS EGWANG OF MED<br />

100,000.<br />

MUYENGA TANK HILL BY PASS LUGWANA FOREIGN NON-EXEMPT<br />

KAMPALA<br />

UGANDA<br />

BIOTECH LABORATORIES IN UGANDA WILL DEVELOP<br />

AND TEST AN INTRANASAL VACCINE TO BE<br />

ADMINISTERED TO YOUNG WOMEN BEFORE PREGNANCY,<br />

AND AGAIN AFTER CHILDBIRTH, TO CONFER<br />

ANTI-MALARIAL IMMUNITY IN THEIR BABIES.<br />

MEDICINE IN NEED CORPORATION NONE TO EXPLORE AND APPLY A SET OF FORMULATION<br />

2,999,904.<br />

104 MOUNT AUBURN STREET 509(A)(1)<br />

CAMBRIDGE, MA 02138<br />

FOR PUBLIC DISCLOSURE<br />

155 OF 519<br />

TECHNOLOGIES TO ALLOW A MALARIA VACCINE<br />

CANDIDATE TO BE MANUFACTURED, TRANSPORTED, AND<br />

DELIVERED TO CHILDREN DEVELOPING COUNTRIES IN<br />

A MORE COST-EFFICIENT PROCESS<br />

ATTACHMENT 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!